Journal
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Volume 872, Issue 1-2, Pages 38-42Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2008.06.052
Keywords
venlafaxine; cloud-point extraction; high-performance liquid chromatography; Triton X-114; pharmacokinetics
Ask authors/readers for more resources
A new straightforward method based on cloud-point extraction (CPE) has been developed, optimized and validated for the determination of venlafaxine in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection. The non-ionic surfactant Triton X-114 (polyethylene glycol tert-octylphenyl ether) Was chosen as the extract solvent. Separation was obtained using a reversed-phase Diamonsil column (C-18, 250 mm x 4.6 mm I.D., 5 mu m) and a mobile phase composed of acetonitrile-phosphate buffer solution (pH 3.0)-triethylamine (33.5:66.5:0.4). Fluorescence detection was used (lambda(ex) 276 nm, lambda(em) 598 nm). Maprotiline was used as the internal standard. Under the optimum conditions, the linear range of venlafaxine in human plasma was 10-800 ng mL(-1) (r(2) = 0.9995). The limit of detection (LOD) was less than 2 ng mL(-1) (S/N = 3) and the limit of quantification (LOQ) was less than 10 ng mL(-1) (S/N = 10). The method Was Successfully applied for the evaluation of pharmacokinetic profiles of venlafaxine capsules in nine healthy volunteers. (c) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available